A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer

Preca BT, Bajdak K, Mock K, Lehmann W, Sundararajan V, Bronsert P, Matzge-Ogi A, Orian-Rousseau V, Brabletz S, Brabletz T, Maurer J, Stemmler M (2017)

Publication Type: Journal article

Publication year: 2017

Journal

Oncotarget Impact Journals

DOI: 10.18632/oncotarget.14563

Abstract

Cancer metastasis is the main reason for poor patient survival. Tumor cells delaminate from the primary tumor by induction of epithelial-mesenchymal transition (EMT). EMT is mediated by key transcription factors, including ZEB1, activated by tumor cell interactions with stromal cells and the extracellular matrix (ECM). ZEB1-mediated EMT and motility is accompanied by substantial cell reprogramming and the acquisition of a stemness phenotype. However, understanding of the underlying mechanism is still incomplete. We identified hyaluronic acid (HA), one major ECM proteoglycan and enriched in mammary tumors, to support EMT and enhance ZEB1 expression in cooperation with CD44s. In breast cancer cell lines HA is synthesized mainly by HAS2, which was already shown to be implicated in cancer progression. ZEB1 and HAS2 expression strongly correlates in various cancer entities and high HAS2 levels associate with an early relapse. We identified HAS2, tumor cell-derived HA and ZEB1 to form a positive feedback loop as ZEB1, elevated by HA, directly activates HAS2 expression. In an in vitro differentiation model HA-conditioned medium of breast cancer cells is enhancing osteoclast formation, an indicator of tumor cell-induced osteolysis that facilitates formation of bone metastasis. In combination with the previously identified ZEB1/ESRP1/CD44s feedback loop, we found a novel autocrine mechanism how ZEB1 is accelerating EMT.

Authors with CRIS profile

Simone Brabletz Lehrstuhl für Experimentelle Medizin II (Molekulare Tumorforschung) Thomas Brabletz Lehrstuhl für Experimentelle Medizin mit dem Schwerpunkt Molekulare Pathogeneseforschung Marc Stemmler Lehrstuhl für Experimentelle Medizin mit dem Schwerpunkt Molekulare Pathogeneseforschung

Involved external institutions

Albert-Ludwigs-Universität Freiburg DE Germany (DE) Karlsruhe Institute of Technology (KIT) DE Germany (DE) Deutsches Krebsforschungszentrum (DKFZ) DE Germany (DE)

How to cite

APA:

Preca, B.-T., Bajdak, K., Mock, K., Lehmann, W., Sundararajan, V., Bronsert, P.,... Stemmler, M. (2017). A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer. Oncotarget. https://doi.org/10.18632/oncotarget.14563

MLA:

Preca, Bogdan-Tiberius, et al. "A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer." Oncotarget (2017).

BibTeX: Download